Kyle Rose
Stock Analyst at Canaccord Genuity
(2.59)
# 1,921
Out of 5,182 analysts
112
Total ratings
51.61%
Success rate
12.92%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $432 → $450 | $189.56 | +137.39% | 17 | Dec 17, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $31.57 | -14.48% | 6 | Feb 26, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $327.51 | +32.82% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $94.87 | -25.16% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $24.10 | +194.61% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.40 | +52.78% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $0.85 | +1,075.50% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $10.90 | +101.83% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $61.57 | +143.63% | 17 | Jul 28, 2023 | |
| SIBN SI-BONE | Maintains: Buy | $24 → $27 | $13.52 | +99.70% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.67 | +2,138.81% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $39.25 | -61.78% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $158.45 | -23.00% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.96 | +1.01% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $10.09 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $91.26 | +36.97% | 7 | Feb 8, 2022 |
Insulet
Dec 17, 2025
Maintains: Buy
Price Target: $432 → $450
Current: $189.56
Upside: +137.39%
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $31.57
Upside: -14.48%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $327.51
Upside: +32.82%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $94.87
Upside: -25.16%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $24.10
Upside: +194.61%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.40
Upside: +52.78%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $0.85
Upside: +1,075.50%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $10.90
Upside: +101.83%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $61.57
Upside: +143.63%
SI-BONE
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $13.52
Upside: +99.70%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $0.67
Upside: +2,138.81%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $39.25
Upside: -61.78%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $158.45
Upside: -23.00%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.96
Upside: +1.01%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $10.09
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $91.26
Upside: +36.97%